Detail akcie Prestige Br Hldg online

Business Summary: Prestige Consumer Healthcare Inc. is a consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
Financial Summary: BRIEF: For the fiscal year ended 31 March 2025, Prestige Consumer Healthcare Inc revenues increased 1% to $1.14B. Net income increased 3% to $214.6M. Revenues reflect North American OTC Healthcare-Gastrointestinal segment increase of 9% to $174.9M, International OTC Healthcare-Gastrointestinal segment increase of 15% to $81.1M, International OTC Healthcare-Dermatologicals segment increase of 41% to $8.2M.